2,855
edits
Psychedelic Therapy Inclusion and Exclusion Criteria: Difference between revisions
Psychedelic Therapy Inclusion and Exclusion Criteria (view source)
Revision as of 01:53, 16 October 2023
, 01:53, 16 October 2023no edit summary
mNo edit summary |
|||
| Line 1: | Line 1: | ||
Certain types of patient are more at risk of adverse side effects to [[Psychedelics|psychedelic]] medicine. Therefore, a judgement needs to be made pre-administration to recommend to the patient where it is safe to take the medicine or not. Below is a list of inclusion criteria | Certain types of patient are more at risk of adverse side effects to [[Psychedelics|psychedelic]] medicine. Therefore, a judgement needs to be made pre-administration to recommend to the patient where it is safe to take the medicine or not. Below is a list of inclusion criteria and exclusion criteria extracted from clinical data up to July 2023<ref>'''Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.''' '''Goodwin, G.M., Croal, M., Feifel, D. ''et al.''''' ''Neuropsychopharmacol.'' (2023). Accessed 15 Jul 2023 via https://www.nature.com/articles/s41386-023-01648-7</ref>. | ||
== Inclusion Criteria == | == Inclusion Criteria == | ||